Drew Thornley

DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand

In Brief This Week: FIND, Sophia Genetics, Dante Labs, BioReference Laboratories, and More

Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests

Siemens Healthineers Q3 Diagnostics Revenues Almost Double on Rapid Antigen Test Demand

Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates

Veracyte Q2 Revenues More Than Double on Test Volume Spike